Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25836763.
- Also identified by DOI 10.1016/j.bone.2015.03.011 and PMC identifier 4591092.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Post-translational modifications of chromatin such as DNA methylation and different types of histone acetylation, methylation and phosphorylation are well-appreciated epigenetic mechanisms that confer information to progeny cells during lineage commitment. These distinct epigenetic modifications have defined roles in bone, development, tissue regeneration, cell commitment and differentiation, as well as disease etiologies. In this review, we discuss the role of these chromatin modifications and the enzymes regulating these marks (methyltransferases, demethylases, acetyltransferases, and deacetylases) in progenitor cells, osteoblasts and bone-related cells. In addition, the clinical relevance of deregulated histone modifications and enzymes as well as current and potential therapeutic interventions targeting chromatin modifiers are addressed.
Medical subject headings
- Bone Development
- Bone Diseases
- Chromatin
- Histone Code